AI assistant
Sending…
BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2012
Mar 19, 2012
31868_dirs_2012-03-19_545372b0-3d88-4f55-a3af-7fd4cf17c985.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2012-03-15
Reporting Person: Sheridan William P (SR VP - CMO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-03-15 | Common Stock | A | 22869 | — | Acquired | 52199 | Direct |
| 2012-03-15 | Common Stock | F | 7543 | $5.23 | Disposed | 44656 | Direct |
Footnotes
F1: Restricted Stock Award-100% vested upon issue with a six month lock up for sale
F2: Shares withheld by BioCryst Pharmaceuticals, Inc. upon the vesting of restricted stock to satisfy the reporting person's tax withholding obligation.
More from BIOCRYST PHARMACEUTICALS INC
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 4
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 24
Regulatory Filings
2026
Mar 20